Additive cardioprotection by pharmacological postconditioning with Hydrogen sulfide and nitric oxide donors in mouse heart: S-sulfhydration vs. S-nitrosylation

Cardiovascular Research

Volumn 110, Issue 1, 2016, Pages 96-106

  Sun, Junhui ^a   Aponte, Angel M ^a   Menazza, Sara ^a   Gucek, Marjan ^a   Steenbergen, Charles ^b   Murphy, Elizabeth ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Hydrogen sulfide; Nitric oxide; Postconditioning; S nitrosylation; S sulfhydration

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; HYDROGEN SULFIDE; N ACETYLPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NOX3 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM BISULFIDE; SULFIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; LIQUID CHROMATOGRAPHY; MALE; MOUSE; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SULFHYDRATION; TANDEM MASS SPECTROMETRY; ANIMAL; C57BL MOUSE; CARDIOTOXICITY; METABOLISM;

ANIMALS; CARDIOTOXICITY; HYDROGEN SULFIDE; ISCHEMIC POSTCONDITIONING; MICE, INBRED C57BL; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE DONORS; SULFIDES;

EID: 84966290881     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvw037     Document Type: Article

References (49)

1. Nicholson CK, Calvert JW. Hydrogen sulfide and ischemia-reperfusion injury. Pharmacol Res 2010;62:289-297.
2. Polhemus DJ, Lefer DJ. Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ Res 2014;114:730-737.
3. Szabó G, Veres G, Radovits T, Geró D, Módis K, Miesel-Gröschel C, Horkay F, Karck M, Szabó C. Cardioprotective effects of hydrogen sulfide. Nitric Oxide 2011;25:201-210.
4. Calvert J, Jha S, Gundewar S, Elrod J, Ramachandran A, Pattillo C, Kevil C, Lefer D. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 2009;105:365-374.
5. Yang G, Zhao K, Ju Y, Mani S, Cao Q, Puukila S, Khaper N, Wu L, Wang R. Hydrogen sulfide protects against cellular senescence via S-sulfhydration of keap1 and activation of Nrf2. Antioxid Redox Signal 2013;18:1906-1919.
6. King AL, Polhemus DJ, Bhushan S, Otsuka H, Kondo K, Nicholson CK, Bradley JM, Islam KN, Calvert JW, Tao Y-X, Dugas TR, Kelley EE, Elrod JW, Huang PL, Wang R, Lefer DJ. Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthasenitric oxide dependent. Proc Natl Acad Sci USA 2014;111:3182-3187.
7. Ji Y, Pang Q-F, Xu G, Wang L, Wang J-K, Zeng Y-M. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury. Eur J Pharmacol 2008;587:1-7.
8. Huang Y-E, Tang Z-H, Xie WEI, Shen X-T, Liu M-H, Peng X-P, Zhao Z-Z, Nie D-B, Liu L-S, Jiang Z-S. Endogenous hydrogen sulfide mediates the cardioprotection induced by ischemic postconditioning in the early reperfusion phase. Exp Ther Med 2012;4:1117-1123.
9. 2S and NO. Methods 2013;62:177-181.
10. 2S signaling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol 2012;13:499-507.
11. 2S signals through protein S-sulfhydration. Sci Signal 2009;2:ra72.
12. Sun J, Murphy E. Protein S-nitrosylation and cardioprotection. Circ Res 2010;106:285-296.
13. Murphy E, Kohr M, Sun J, Nguyen T, Steenbergen C. S-nitrosylation: a radical way to protect the heart. J Mol Cell Cardiol 2012;52:568-577.
14. Predmore BL, Kondo K, Bhushan S, Zlatopolsky MA, King AL, Aragon JP, Grinsfelder DB, Condit ME, Lefer DJ. The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability. Am J Physiol 2012;302:H2410-H2418.
15. Altaany Z, Ju Y, Yang G, Wang R. The coordination of S-sulfhydration, S-nitrosylation, and phosphorylation of endothelial nitric oxide synthase by hydrogen sulfide. Sci Signal 2014;7:ra87.
16. Jaffrey SR, Snyder SH. The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001;86:PL1.
17. Zhang D, Macinkovic I, Devarie-Baez NO, Pan J, Park C-M, Carroll KS, Filipovic MR, Xian M. Detection of protein S-sulfhydration by a tag-switch technique. Angew Chem Int Ed Engl 2014;53:575-581.
18. Murray CI, Chung H, Uhrigshardt H, Van Eyk JE. Quantification of mitochondrial S-nitrosylation by cysTMT (6) switch assay. Methods Mol Biol 2013;1005:169-179.
19. Kohr MJ, Aponte A, Sun J, Gucek M, Steenbergen C, Murphy E. Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags. Circ Res 2012;111:1308-1312.
20. Bell RM, Maddock HL, Yellon DM. The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart. Cardiovasc Res 2003;57:405-415.
21. Yong QC, Lee SW, Foo CS, Neo KL, Chen X, Bian J-S. Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning. Am J Physiol 2008;295:H1330-H1340.
22. Tong G, Aponte AM, Kohr MJ, Steenbergen C, Murphy E, Sun J. Postconditioning leads to an increase in protein S-nitrosylation. Am J Physiol 2014;306:H825-H832.
23. Yong Q-C, Cheong JL, Hua F, Deng L-W, Khoo YM, Lee H-S, Perry A, Wood M, Whiteman M, Bian J-S. Regulation of heart function by endogenous gaseous mediators-crosstalk between nitric oxide and hydrogen sulfide. Antioxid Redox Signal 2011;14:2081-2091.
24. Yong Q-C, Hu L-F, Wang S, Huang D, Bian J-S. Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl. Cardiovasc Res 2010;88:482-491.
25. Cohen MV, Yang X-M, Liu Y, Solenkova NV, Downey JM. Cardioprotective PKG-independent NO signaling at reperfusion. Am J Physiol 2010;299:H2028-H2036.
26. Pan J, Carroll KS. Persulfide reactivity in the detection of protein S-sulfhydration. ACS Chem Biol 2013;8:1110-1116.
27. Mir S, Sen T, Sen N. Cytokine-induced gapdh sulfhydration affects PSD95 degradation and memory. Mol Cell 2014;56:786-795.
28. Sen N, Paul Bindu D, Gadalla Moataz M, Mustafa Asif K, Sen T, Xu R, Kim S, Snyder Solomon H. Hydrogen sulfide-linked sulfhydration of NF-kB mediates its antiapoptotic actions. Mol Cell 2012;45:13-24.
29. 2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning. Br J Pharmacol 2015;172:1587-1606.
30. Pabla R, Buda AJ, Flynn DM, Salzberg DB, Lefer DJ. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am J Physiol 1995;269:H1113-H1121.
31. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs. Circulation 1993;88:2337-2350.
32. Penna C, Perrelli M-G, Tullio F, Moro F, Parisella M, Merlino A, Pagliaro P. Post-ischemic early acidosis in cardiac postconditioning modifies the activity of antioxidant enzymes, reduces nitration, and favors protein S-nitrosylation. Pflugers Arch 2011;462:219-233.
33. Penna C, Perrelli MG, Tullio F, Angotti C, Camporeale A, Poli V, Pagliaro P. Diazoxide postconditioning induces mitochondrial protein S-nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of risk elements: no role for SAFE. Basic Res Cardiol 2013;108:371.
34. Methner C, Lukowski R, Grube K, Loga F, Smith RJ, Murphy M, Hofmann F, Krieg T. Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G. Basic Res Cardiol 2013;108:337.
35. Elrod J, Calvert J, Morrison J, Doeller J, Kraus D, Tao L, Jiao X, Scalia R, Kiss L, Szabo C. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 2007;104:15560-15565.
36. King S. Potential biological chemistry of hydrogen sulfide (H2S) with the nitrogen oxides. Free Rad Biol Med 2013;55:1-7.
37. Bianco CL, Fukuto JM. Examining the reaction of NO and H2S and the possible cross-talk between the two signaling pathways. Proc Natl Acad Sci USA 2015;112:10573-10574.
38. Sojitra B, Bulani Y, Putcha U, Kanwal A, Gupta P, Kuncha M, SK B. Nitric oxide synthase inhibition abrogates hydrogen sulfide-induced cardioprotection in mice. Mol Cell Biochem 2012;360:61-69.
39. Kida M, Sugiyama T, Yoshimoto T, Ogawa Y. Hydrogen sulfide increases nitric oxide production with calcium-dependent activation of endothelial nitric oxide synthase in endothelial cells. Eur JPharm Sci 2013;48:211-215.
40. Minamishima S, Bougaki M, Sips PY, De Yu J, Minamishima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F. Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 2009;120:888-896.
41. Bibli S-I, Andreadou I, Chatzianastasiou A, Tzimas C, Sanoudou D, Kranias E, BrouckaertP, Coletta C, Szabo C, Kremastinos DT, Iliodromitis EK, Papapetropoulos A. Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway. Cardiovasc Res 2015;106:432-442.
42. Filipovic MR, Miljkovic JL, Nauser T, Royzen M, Klos K, Shubina T, Koppenol WH, Lippard SJ, Ivanovi-Burmazovi I. Chemical characterization of the smallest S-nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols. JAmChemSoc 2012;134:12016-12027.
43. Whiteman M, Li L, Kostetski I, Chu SH, Siau JL, Bhatia M, Moore PK. Evidence for the formation ofa novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 2006;343:303-310.
44. Filipovic MR, Eberhardt M, Prokopovic V, Mijuskovic A, Orescanin-Dusic Z, Reeh P, Ivanovic-Burmazovic I. Beyond H2S and NO interplay: hydrogen sulfide and nitroprusside react directly to give nitroxyl (HNO). A new pharmacological source of HNO. J Med Chem 2013;56:1499-1508.
45. Gao WD, Murray CI, Tian Y, Zhong X, DuMond JF, Shen X, Stanley BA, Foster DB, Wink DA, King SB, Van Eyk JE, Paolocci N. Nitroxyl-mediated disulfide bond formation between cardiac myofilament cysteines enhances contractile function. Circ Res 2012;111:1002-1011.
46. Cortese-Krott MM, Kuhnle GGC, Dyson A, Fernandez BO, Grman M, DuMond JF, Barrow MP, McLeod G, Nakagawa H, Ondrias K, Nagy P, King SB, Saavedra JE, Keefer LK, Singer M, Kelm M, Butler AR, Feelisch M. Key bioactive reaction products of the NO/H2S interaction are S/N-hybrid species, polysulfides, and nitroxyl. Proc Natl Acad Sci USA 2015;112:E4651-E4660.
47. Sun J, Steenbergen C, Murphy E. S-nitrosylation: NO-related redox signaling to protect against oxidative stress. Antioxid Redox Signal 2006;8:1693-1705.
48. Wang S-B, Foster DB, Rucker J, O'Rourke B, Kass DA, Van Eyk JE. Redox regulation of mitochondrial ATP synthase: implications for cardiac resynchronization therapy. Circ Res 2011;109:750-757.
49. Nguyen TT, Stevens MV, Kohr M, Steenbergen C, Sack MN, Murphy E. Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem 2011;286:40184-40192.